Skip to main content

Table 1 Characteristics of study patients, overall and by sex.

From: Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients

 

Overall (n=74)

Males (n = 277)

Females (n = 197)

p

Age (years)

54.10 ± 7.27

54.09 ± 7.49

54.12 ± 6.97

0.962

Obese (BMI > 30)

153 (32.3%)

92 (33.2%)

61 (31.0%)

0.606

Smokers

111 (23.4%)

69 (24.9%)

42 (21.3%)

0.363

Diabetics

73 (15.4%)

52 (18.8%)

21 (10.7%)

0.016

Hyperlipidaemic

314 (66.2%)

174 (62.8%)

140 (71.1%)

0.038

BMI

28.72 ± 4.71

28.91 ± 4.14

28.46 ± 5.41

0.310

Waist circumference

96.04 ± 12.38

100.10 ± 9.99

90.28 ± 13.15

0.000

Glucose (mg/dL)

100.28 ± 28.04

103.32 ± 30.76

95.94 ± 23.00

0.006

Cholesterol/HDL ratio

4.12 ± 1.09

4.38 ± 1.12

3.76 ± 0.94

0.000

Total cholesterol (mg/dL)

214.70 ± 35.92

211.70 ± 36.17

218.92 ± 35.22

0.031

HDL-C (mg/dL)

54.85 ± 14.44

50.54 ± 12.34

60.92 ± 15.01

0.000

LDL-C (mg/dL)

134.18 ± 32.99

134.37 ± 32.46

133.92 ± 33.83

0.888

Triglycerides (mg/dL)

115.26 ± 73.81

137.79 ± 80.32

128.38 ± 61.47

0.001

Systolic blood pressure (mmHg)

140.99 ± 18.92

142.86 ± 16.49

138.37 ± 21.65

0.011

Diastolic blood pressure (mmHg)

89.09 ± 10.40

89.70 ± 9.67

88.24 ± 11.32

0.132

Antihypertensive drugs

271 (57.2%)

159 (57.4%)

112 (56.9%)

0.905

Lipid lowering drugs

75 (15.8%)

52 (18.8%)

23 (11.7%)

0.037

CVR by SCORE*

2.97 ± 4

3.94 ± 4.66

1.61 ± 2.18

0.000

CVR by D'Agostino**

18.00 ± 13.45

22.88 ± 14.66

11.12 ± 7.22

0.000

  1. Hyperlipidaemic: cholesterol > 200 mg/dl. BMI: body mass index; HDL: high-density lipoprotein; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol. CVR: cardiovascular risk. Significant differences between males and females. P value: Differences between males and females. Data are shown as mean ± standard deviation or as number and percentages. *Cardiovascular mortality risk as percent risk and estimated at 10 years. **Cardiovascular morbidity and mortality risk as percent risk and estimated at 10 years.